GARFT inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GARFT inhibitor, covering 2012-05-10 to 2012-05-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]